Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCS12 versus etonogestrel implant discontinuation study in women seeking contraception
2010-023911-32Phase 3Completed
- Sponsor
- Bayer
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in contraception comparing LCS12 arm with Etonogestrel subdermal implant arm (2 arms). Primary endpoint: Discontinuation rate at month 12. Started Mar 2011; status: completed.
02
Drugs
LoviOneetonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2010-023911-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023911-32.